Mid-term results of endovascular treatment for the transplanted renal arterial stenosis

Ying Wang, Hongpeng Zhang, Xiao-ping Liu, Li-jun Wang, Xin Jia, J. Xiong, XiaoHui Ma, W. Guo
{"title":"Mid-term results of endovascular treatment for the transplanted renal arterial stenosis","authors":"Ying Wang, Hongpeng Zhang, Xiao-ping Liu, Li-jun Wang, Xin Jia, J. Xiong, XiaoHui Ma, W. Guo","doi":"10.3760/CMA.J.ISSN.1007-631X.2020.01.011","DOIUrl":null,"url":null,"abstract":"Objective \nTo investigate the safety and mid- term efficacy of percutaneous endovascular angioplasty(PTA) and stent implantation for transplantation renal arterial stenosis(TRAS) . \n \n \nMethods \nRetrospective analysis was performed on 18 patients with TRAS admitted to of department vascular surgery, PLA General Hospital from Jan 2011 to Dec 2018. \n \n \nResults \nPTA and stent implantation were performed in all 18 patients via ipsilateral or contralateral femoral artery including 4 cases of PTA alone, 8 cases of PTA plus stent, 6 cases of stent implanted directly.Three of the 18 patients underwent ipsilateral femoral artery catheterization and 15 underwent contralaterally.A total of 14 stents were implanted, all of were balloon expanding stents, of which 2 were drug-coated stents, and the technical success rate was 100%.The average dosage of contrast agent was 64 ml, the stenosis rate of renal artery before interventional treatment was 50%-99%, and that after interventional treatment reduced to 10%-30%.The systolic blood pressure decreased from (157.2±43.0) mmHg preoperatively to (129.8±8.6) mmHg postoperatively.The SCr level decreased from (258.8±214.7) μmol/L to (176.3±101.1) μmol/L. Preoperative urea nitrogen decreased from (15.7±1.6) mmol/L to (10.6±1.1) mmol/L postoperatively (P<0.05). Mean postoperative follow-up time was 42.4 months (3-93 months).17 cases were cured, 1 case was ineffective, 1 case suffered restenosis after 30 days, and was given remedy PTA plus stenting. \n \n \nConclusions \nTRAS is a vascular factor leading to grafted renal failure, the endovascular treatment of TRAS is safe, effective and has good mid-term result. \n \n \nKey words: \nKidney transplantation; Renal artery obstruction; Angioplasty; Stent","PeriodicalId":66425,"journal":{"name":"中华普通外科杂志","volume":"35 1","pages":"38-41"},"PeriodicalIF":0.0000,"publicationDate":"2020-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"中华普通外科杂志","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3760/CMA.J.ISSN.1007-631X.2020.01.011","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective To investigate the safety and mid- term efficacy of percutaneous endovascular angioplasty(PTA) and stent implantation for transplantation renal arterial stenosis(TRAS) . Methods Retrospective analysis was performed on 18 patients with TRAS admitted to of department vascular surgery, PLA General Hospital from Jan 2011 to Dec 2018. Results PTA and stent implantation were performed in all 18 patients via ipsilateral or contralateral femoral artery including 4 cases of PTA alone, 8 cases of PTA plus stent, 6 cases of stent implanted directly.Three of the 18 patients underwent ipsilateral femoral artery catheterization and 15 underwent contralaterally.A total of 14 stents were implanted, all of were balloon expanding stents, of which 2 were drug-coated stents, and the technical success rate was 100%.The average dosage of contrast agent was 64 ml, the stenosis rate of renal artery before interventional treatment was 50%-99%, and that after interventional treatment reduced to 10%-30%.The systolic blood pressure decreased from (157.2±43.0) mmHg preoperatively to (129.8±8.6) mmHg postoperatively.The SCr level decreased from (258.8±214.7) μmol/L to (176.3±101.1) μmol/L. Preoperative urea nitrogen decreased from (15.7±1.6) mmol/L to (10.6±1.1) mmol/L postoperatively (P<0.05). Mean postoperative follow-up time was 42.4 months (3-93 months).17 cases were cured, 1 case was ineffective, 1 case suffered restenosis after 30 days, and was given remedy PTA plus stenting. Conclusions TRAS is a vascular factor leading to grafted renal failure, the endovascular treatment of TRAS is safe, effective and has good mid-term result. Key words: Kidney transplantation; Renal artery obstruction; Angioplasty; Stent
血管内治疗移植性肾动脉狭窄的中期疗效
目的探讨经皮血管内成形术(PTA)联合支架植入术治疗移植性肾动脉狭窄(TRAS)的安全性和中期疗效。方法对2011年1月至2018年12月解放军总医院血管外科收治的18例TRAS患者进行回顾性分析。结果18例患者均经同侧或对侧股动脉行PTA联合支架植入术,其中单独PTA 4例,PTA联合支架8例,直接置入支架6例。18例患者中3例行同侧股动脉插管,15例行对侧股动脉插管。共植入14个支架,均为球囊扩张支架,其中药物包被支架2个,技术成功率为100%。造影剂平均剂量为64 ml,介入治疗前肾动脉狭窄率为50%-99%,介入治疗后肾动脉狭窄率降至10%-30%。收缩压由术前(157.2±43.0)mmHg降至术后(129.8±8.6)mmHg。SCr水平由(258.8±214.7)μmol/L降至(176.3±101.1)μmol/L。术前尿素氮由(15.7±1.6)mmol/L降至术后(10.6±1.1)mmol/L (P<0.05)。术后平均随访42.4个月(3 ~ 93个月)。治愈17例,无效1例,30天后再狭窄1例,给予PTA加支架植入术治疗。结论TRAS是导致移植物肾衰的血管因素,血管内治疗TRAS安全有效,中期效果良好。关键词:肾移植;肾动脉阻塞;血管成形术;支架
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
9825
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信